SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-050569
Filing Date
2010-09-23
Accepted
2010-09-23 09:15:42
Documents
4
Period of Report
2010-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v197220_8k.htm 8-K 31064
2 v197220_ex4-1.htm EX-4.1 99462
3 v197220_ex4-2.htm EX-4.2 99476
4 v197220_ex10-1.htm EX-10.1 126635
  Complete submission text file 0001144204-10-050569.txt   358348
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 101085665
SIC: 4731 Arrangement of Transportation of Freight & Cargo